1st half day 2nd half day dash 1st half month 2nd half month dash 1st digit year 2nd digit year 3rd digit year last digit year
FDA Taking Time Over Once A Day Cialis

Written by Stuart Stevens | Wednesday, 07 November 2007 | There are 0 comments

Cialis is the erectile dysfunction drug which works for 36 hours

Eli Lilly, the drug company that produces the erectile dysfunction medication Cialis was hoping to get a positive answer from the Food & Drug Administration in America regarding a new version of their impotence pill last week. The idea is that Eli Lilly want to produce a Once A Day and version of Cialis for men who do not appreciate the idea of having to pop a pill before having sexual intercourse and who want to be ready and able to maintain an erection at any time.

FDA Taking Time Over Once A Day Cialis

Cialis is the erectile dysfunction drug which works for 36 hours and the concept is that if a small tablet could be taken every 24 hours men would be in a situation where they had good erectile function all the time. However not everything is going as to plan as the Food & Drug Administration have informed Eli Lilly that they require more information regarding the Once A Day Cialis medication. The news is not actually that bad as the Food & Drug Administration have not required extra testing but merely said that they wanted to have an additional look at “existing data”.

The EMEA which is the health authority regulating medicines in Europe has already given the green light to the Cialis Once A Day Medication. Some people say that this medication is perfect for men who are always optimistic about the chances of getting sexual intercourse and who do not want to ruin the foreplay aspect of sex by fumbling for a pill and having to get a glass of water to drink it with.

Cialis has the fastest growing sales of all erectile dysfunction drugs and this is mainly because it is a drug that works for 36 hours opposed to the four hour time window for sex that Viagra and Levitra give men.

© 2010 This content has been exclusively written by UKMedix [request source information]
ChatterBack with UKMedixGoto ChatterBack with UKMedix

There are 0 comments on this article.

Name :  *
Comment :  *
  Secure Image
Code :  * (please enter the code above)
 

Fields marked with  * are required.